Anti-interference apolipoprotein E determination kit, preparation method and detection method
By adding a stabilizer and a buffer system to the apolipoprotein E assay kit, the inaccurate detection problem caused by antibody precipitation is solved, the stability and accuracy of the kit are achieved, and it is suitable for a wide range of biochemical instrument detection.
Patent Information
- Application Number
- CN202411029965.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
AI Technical Summary
The antibodies in the existing apolipoprotein E assay kits are prone to precipitation during storage, resulting in inaccurate test results and poor repetition, which cannot meet the needs of doctors and patients.
By adding the stabilizers carboxymethyl chitosan and glycerol to the R2 reagent formula, a buffer system is formed to control the pH value, and substances such as sodium azide, polyethyleneimine and sodium dodecylbenzenesulfonate are used. , ensure the stability and uniform distribution of the antibodies, and prepare anti-interference apolipoprotein E assay kit and detection method.
It achieves stable performance, low cost, accurate detection results and good repeatability of the kit. It is suitable for various biochemical instruments, and solves the problem of inaccurate detection caused by antibody precipitation.
Smart Images

Figure CN118962162A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of immunoturbidimetric in vitro diagnosis, and in particular to an anti-interference apolipoprotein E determination kit, a preparation method and a detection method. Background Art
[0002] Apolipoprotein E (Apo E) has three similar subtypes, Apo E2, Apo E3 and Apo E4, of which Apo E3 is the most common. It is mainly involved in the body's blood lipid metabolism and regulates the body's blood lipid levels. It is closely related to the occurrence and development of cardiovascular diseases such as dyslipidemia, hypertension, and heart failure, and can be used to predict the risk of cardiovascular disease. In addition to being related to cardiovascular diseases, its gene polymorphism is also associated with other diseases, such as E4 is related to Alzheimer's disease. Clinical laboratory diagnostic methods: one-way immunodiffusion, latex agglutination, rate scattering turbidimetry, immunoturbidimetry, latex-enhanced immunoturbidimetry, immunolabeling technology, etc.
[0003] Test Principle: Apo E in the sample meets the corresponding antibody in the reagent and immediately forms an antigen-antibody immune complex, which forms turbidity in a specific buffer environment. The turbidity is proportional to the antigen content when the appropriate antibody concentration is present. By comparing with the calibrator operated under the same conditions, the Apo E content in the sample can be calculated.
[0004] Because Apo E antibodies are very unstable and have poor anti-interference ability, in order to overcome this difficulty, this patent adds stabilizers carboxymethyl chitosan and propylene glycol to the R2 reagent formula to maintain the stability of Apo E antibodies; tris(hydroxymethyl)aminomethane and hydrochloric acid are used to form a buffer system to control the appropriate pH value to be between 6.8-7.6; sodium azide is an antibacterial agent to inhibit bacterial growth; polyethyleneimine and sodium dodecylbenzene sulfonate can make the distribution of antibodies more uniform.
[0005] Most of the reagents currently on the market have some shortcomings. For example, antibodies are prone to precipitation during the storage process, which leads to poor antibody performance, poor repeatability, and a larger coefficient of variation, which directly causes inaccurate reagent test results and cannot meet the needs of doctors and patients. Summary of the invention
[0006] The purpose of the present invention is to provide an anti-interference apolipoprotein E assay kit, a preparation method and a detection method, aiming to solve the problem that the antibodies in the currently marketed reagents are prone to precipitation during storage, resulting in inaccurate reagent detection results.
[0007] To achieve the above object, in a first aspect, the present invention provides a method for preparing an anti-interference apolipoprotein E assay kit, comprising the following steps:
[0008] Weigh 5-6 parts of polyethylene glycol, 3-12 parts of sodium azide, 2-15 parts of Tween, 1000-1650 parts of purified water, 0.45-0.55 parts of tris(hydroxymethyl)aminomethane) and 15-23 parts of hydrochloric acid respectively, mix well, and filter to obtain a first reagent;
[0009] Respectively weigh 3-8 parts of water-soluble polyethyleneimine, 1-4 parts of sodium dodecylbenzene sulfonate, 2-5 parts of carboxymethyl chitosan, 2-6 parts of glycerol, 1-4 parts of sodium chloride, 1-3 parts of tris(hydroxymethyl)aminomethane, 0.01-0.02 parts of hydrochloric acid, 1-2 parts of sodium azide, 1-3 parts of citric acid, 3-20 parts of Apo E goat anti-human antibody and 40-55 parts of purified water, mix well, and filter to obtain a second reagent;
[0010] Add 1 L of standard diluent to Apo E antigen to obtain Apo E calibrator.
[0011] The mixing of the first reagent and the second reagent should be carried out under the condition of 25±3°C.
[0012] Wherein, the first reagent, the second reagent and the Apo E calibrator are all stored at 2-8°C.
[0013] Wherein, the Apo E calibrator concentrations include S1=0 mg / L, S1=12.5 mg / L, S2=25.0 mg / L, S3=50.0 mg / L and S1=100.0 mg / L.
[0014] In a second aspect, the present invention also provides an interference-resistant apolipoprotein E assay kit, comprising a first reagent, a second reagent and an Apo E calibrator.
[0015] In a third aspect, the present invention also provides an anti-interference apolipoprotein E assay kit detection method, comprising the following steps:
[0016] Adding the first reagent to the sample to be tested and mixing to obtain a mixed solution, incubating the first mixed solution at 37° C., and reading a first absorbance at a wavelength of 340 nm;
[0017] The second reagent is added to the mixed solution and mixed evenly, incubated at 37° C., and the second absorbance is read at a wavelength of 340 nm;
[0018] Subtracting the second absorbance from the first absorbance to obtain an absorbance difference;
[0019] The Apo E calibrator is used to fit a standard curve on a fully automatic biochemical analyzer, and the content of Apo E in the sample to be tested is calculated based on the absorbance.
[0020] The invention discloses a method for preparing an anti-interference apolipoprotein E assay kit. The method comprises the following steps: respectively weighing 5-6 parts of polyethylene glycol, 3-12 parts of sodium azide, 2-15 parts of Tween, 1000-1650 parts of purified water, 0.45-0.55 parts of tris(hydroxymethyl)aminomethane) and 15-23 parts of hydrochloric acid, mixing them evenly, and filtering them to obtain a first reagent; respectively weighing 3-8 parts of water-soluble polyethyleneimine, 1-4 parts of sodium dodecylbenzenesulfonate, 2-5 parts of carboxymethyl chitosan, 2-6 parts of glycerol, 1-4 parts of sodium chloride, 1-3 parts of tris(hydroxymethyl)aminomethane, 0.01-0.02 parts of hydrochloric acid, 1-2 parts of sodium azide, 1-3 parts of citric acid, 3-20 parts of Apo E goat anti-human antibody and 40-55 parts of purified water, mixing them evenly, and filtering them to obtain a second reagent; and mixing Apo E 1L of E antigen standard diluent was used to obtain ApoE calibrators of different concentrations. The kit prepared by this method has no precipitation, stable performance, low cost, accurate test results, good repeatability, and can be widely used in various biochemical analyzers. It has a wider versatility and solves the problem that the antibodies in the currently listed reagents are prone to precipitation during the storage process, resulting in inaccurate reagent test results. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0022] Figure 1 The present invention provides a flow chart of a method for preparing an anti-interference apolipoprotein E assay kit.
[0023] Figure 2 The present invention provides a flow chart of the detection method of the anti-interference apolipoprotein E determination kit. DETAILED DESCRIPTION
[0024] Embodiments of the present invention are described in detail below, examples of which are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and should not be construed as limiting the present invention.
[0025] See also Figure 1 In a first aspect, the present invention provides a method for preparing an anti-interference apolipoprotein E assay kit, comprising the following steps:
[0026] S1: Weigh 5-6 parts of polyethylene glycol, 3-12 parts of sodium azide, 2-15 parts of Tween, 1000-1650 parts of purified water, 0.45-0.55 parts of tris(hydroxymethyl)aminomethane) and 15-23 parts of hydrochloric acid, mix well, and filter to obtain a first reagent;
[0027] Specifically, by weight, 5-6 parts of polyethylene glycol, 3-12 parts of sodium azide, 2-15 parts of Tween, 1000-1650 parts of purified water, 0.45-0.55 parts of tris(hydroxymethyl)aminomethane, and 15-23 parts of hydrochloric acid are weighed respectively, mixed evenly at 25±3°C, filtered to obtain the first reagent (reagent R1), and then stored at 2-8°C.
[0028] S2: 3-8 parts of water-soluble polyethyleneimine, 1-4 parts of sodium dodecylbenzenesulfonate, 2-5 parts of carboxymethyl chitosan, 2-6 parts of glycerol, 1-4 parts of sodium chloride, 1-3 parts of tris(hydroxymethyl)aminomethane, 0.01-0.02 parts of hydrochloric acid, 1-2 parts of sodium azide, 1-3 parts of citric acid, 3-20 parts of Apo E goat anti-human antibody and 40-55 parts of purified water are weighed and mixed evenly, and filtered to obtain a second reagent;
[0029] Specifically, 3-8 parts of water-soluble polyethyleneimine, 1-4 parts of sodium dodecylbenzene sulfonate, 2-5 parts of carboxymethyl chitosan, 2-6 parts of glycerol, 1-4 parts of sodium chloride, 1-3 parts of tris(hydroxymethyl)aminomethane, 0.01-0.02 parts of hydrochloric acid, 1-2 parts of sodium azide, 1-3 parts of citric acid, 3-20 parts of Apo E sheep anti-human antibody, and 40-55 parts of purified water are weighed respectively by weight, mixed evenly at 25±3°C, filtered to obtain the second reagent (reagent R2), and then stored at 2-8°C.
[0030] S3 dilute the Apo E antigen with 1 L of standard diluent to obtain an Apo E calibrator.
[0031] Specifically, the Apo E antigen is diluted with 1L of a standard diluent (3-6 parts of citric acid monohydrate, 5-18 parts of sodium chloride, 1-6 parts of sodium azide, 2.3-6 parts of sodium hydroxide, 3.7-9 parts of sodium dodecylbenzene sulfonate, 2-15 parts of tris(hydroxymethylaminomethane), 3-16 parts of hydrochloric acid, 3-7 parts of arginine, 3-8 parts of polyethyleneimine, 40-55 parts of purified water, and diluted with the calibrator to obtain Apo E calibrators of different concentrations), and then stored at 2-8°C;
[0032] In a second aspect, the present invention also provides an interference-resistant apolipoprotein E assay kit, comprising a first reagent, a second reagent and an Apo E calibrator.
[0033] Specifically, the Apo E calibrator concentrations include S1=0 mg / L, S1=12.5 mg / L, S2=25.0 mg / L, S3=50.0 mg / L and S1=100.0 mg / L.
[0034] See also Figure 2 In a third aspect, the present invention also provides an anti-interference apolipoprotein E assay kit detection method, comprising the following steps:
[0035] S01: adding the first reagent to the sample to be tested and mixing to obtain a mixed solution, incubating the first mixed solution at 37° C., and reading a first absorbance at a wavelength of 340 nm;
[0036] S02: adding the second reagent to the mixed solution, mixing, incubating at 37° C., and reading the second absorbance at a wavelength of 340 nm;
[0037] S03 subtracting the second absorbance from the first absorbance to obtain an absorbance difference;
[0038] S04 uses the Apo E calibrator to fit a standard curve on a fully automatic biochemical analyzer, and calculates the content of Apo E in the sample to be tested based on the absorbance.
[0039] The sources of raw materials involved in the Apo E detection kit provided in the present invention are shown in Table 1:
[0040] raw material source Polyethylene glycol Guangdong Guanghua Technology Co., Ltd. Sodium Azide Shanghai Xibao Biotechnology Co., Ltd. Twain Shanghai Xibao Biotechnology Co., Ltd. Tris(hydroxymethyl)aminomethane Shanghai Xibao Biotechnology Co., Ltd. hydrochloric acid Shanghai Xibao Biotechnology Co., Ltd. Sodium chloride Shanghai Xibao Biotechnology Co., Ltd. Citric Acid Shanghai Xibao Biotechnology Co., Ltd. ApoE goat anti-human antibody Feipeng Biotechnology Co., Ltd. Sodium hydroxide Shanghai Xibao Biotechnology Co., Ltd. Polyvinylpyrrolidine Shanghai Xibao Biotechnology Co., Ltd. Sodium dodecylbenzenesulfonate Shanghai Xibao Biotechnology Co., Ltd. Polyethyleneimine Feipeng Biotechnology Co., Ltd. Carboxymethyl chitosan Shanghai Xibao Biotechnology Co., Ltd. Glycerol Shanghai Xibao Biotechnology Co., Ltd.
[0041] Table 1
[0042] In order to better understand the present technical solution, the following embodiments are provided for further explanation:
[0043] Example 1
[0044] Apo E Detection Kit
[0045] Reagent R1
[0046] Reagent name Dosage Polyethylene glycol 3 servings Sodium Azide 4 servings Twain 1 serving Tris(hydroxymethyl)aminomethane 2.3 servings hydrochloric acid 0.023 parts
[0047] Reagent R2
[0048] Reagent name Dosage Polyethylene glycol 5 servings Sodium Azide 7 servings ApoE goat anti-human antibody 2 servings Tris(hydroxymethyl)aminomethane 3 servings hydrochloric acid 0.03 parts Sodium chloride 9 servings Polyethyleneimine 6 servings Sodium dodecylbenzenesulfonate 2 servings Carboxymethyl chitosan 3 servings Glycerol 2 servings
[0049] Calibrator: Apo E antigen standard diluent (3 parts citric acid monohydrate, 7 parts sodium chloride, 1 part sodium azide, 2.3 parts sodium hydroxide, 3.7 parts sodium dodecylbenzene sulfonate, 2 parts tris(hydroxymethylaminomethane), 3 parts hydrochloric acid, 5 parts arginine and 3 parts polyethyleneimine).
[0050] Example 2
[0051] Apo E Detection Kit
[0052] Reagent R1
[0053] Reagent name Dosage Polyethylene glycol 4 servings Sodium Azide 5 servings Twain 3 servings Tris(hydroxymethyl)aminomethane 5 servings hydrochloric acid 0.06
[0054] Reagent R2
[0055] Reagent name Dosage Polyethylene glycol 4 servings Sodium Azide 5 servings ApoE goat anti-human antibody 7 servings Tris(hydroxymethyl)aminomethane 6 servings hydrochloric acid 0.08 Sodium chloride 7 servings Polyethyleneimine 5 servings Carboxymethyl chitosan 1 serving Sodium dodecylbenzenesulfonate 3 servings Glycerol 4 servings
[0056] Calibrator: Apo E antigen standard diluent (3 parts citric acid monohydrate, 9 parts sodium chloride, 2 parts sodium azide, 2.3 parts sodium hydroxide, 3.7 parts sodium dodecylbenzene sulfonate, 3 parts tris(hydroxymethylaminomethane), 4 parts hydrochloric acid, 6 parts arginine and 3 parts polyethyleneimine).
[0057] Example 3
[0058] Apo E Detection Kit
[0059] Reagent R1
[0060] Reagent name Dosage Polyethylene glycol 5 servings Sodium Azide 5 servings Twain 4 servings Tris(hydroxymethyl)aminomethane 8 servings hydrochloric acid 0.07
[0061] Reagent R2
[0062] Reagent name Dosage Polyethylene glycol 6 servings Sodium Azide 11 servings ApoE goat anti-human antibody 8 servings Tris(hydroxymethyl)aminomethane 13 servings hydrochloric acid 0.11 parts Sodium chloride 7 servings Polyethyleneimine 9 servings Carboxymethyl chitosan 5 servings Sodium dodecylbenzenesulfonate 2 servings Glycerol 3 servings
[0063] Calibrator: Apo E antigen standard diluent (4 parts citric acid monohydrate, 7 parts sodium chloride, 1 part sodium azide, 2.9 parts sodium hydroxide, 3.9 parts sodium dodecylbenzene sulfonate, 2.4 parts tris(hydroxymethylaminomethane), 3.8 parts hydrochloric acid, 5.9 parts arginine and 5 parts polyethyleneimine).
[0064] Example 4
[0065] Apo E Detection Kit
[0066] Reagent R1
[0067] Reagent name Dosage Polyethylene glycol 8 servings Sodium Azide 7 servings Twain 4 servings Tris(hydroxymethyl)aminomethane 6 servings hydrochloric acid 0.07
[0068] Reagent R2
[0069] Reagent name Dosage Polyethylene glycol 15 servings Sodium Azide 18 servings ApoE goat anti-human antibody 15 servings Tris(hydroxymethyl)aminomethane 9 servings hydrochloric acid 0.08 Sodium chloride 9 servings Polyethyleneimine 6 servings Carboxymethyl chitosan 2 servings Sodium dodecylbenzenesulfonate 3 servings Glycerol 5 servings
[0070] Calibrator: Apo E antigen standard diluent (3.8 parts citric acid monohydrate, 8 parts sodium chloride, 1.8 parts sodium azide, 2.7 parts sodium hydroxide, 3.7 parts sodium dodecylbenzene sulfonate, 4 parts tris(hydroxymethylaminomethane), 5 parts hydrochloric acid, 6 parts arginine and 7 parts polyethyleneimine).
[0071] Example 5
[0072] Apo E Detection Kit
[0073] Reagent R1
[0074] Reagent name Dosage Polyethylene glycol 15 servings Sodium Azide 12 servings Twain 17 servings Tris(hydroxymethyl)aminomethane 13 servings hydrochloric acid 0.012
[0075] Reagent R2
[0076]
[0077]
[0078] Calibrator: 1L of Apo E antigen standard diluent (6 parts of citric acid monohydrate, 9 parts of sodium chloride, 1 part of sodium azide, 3 parts of sodium hydroxide, 7 parts of sodium dodecylbenzenesulfonate, 8 parts of tris(hydroxymethylaminomethane), 0.08 parts of hydrochloric acid, 4 parts of arginine and 2 parts of polyethyleneimine).
[0079] Comparison of test results of different embodiments
[0080] 1. Prepare a sample with an Apo E concentration of 25.2 mg / L respectively, and repeat the test on the sample using the kit of Example 1. The test results are shown in Table 2:
[0081] / 0 months 4 months 8 months 12 months 13 months 14 months 1 25.6 25.8 25.6 25.7 25.6 25.8 2 25.6 25.7 25.7 25.8 25.9 25.9 3 25.6 25.9 25.9 25.9 25.6 25.7 Theoretical concentration 25.2 25.2 25.2 25.2 25.2 25.2 Relative deviation 1 1.67% 2.38% 1.75% 1.91% 1.67% 2.54% Relative deviation 2 1.71% 2.03% 1.95% 2.62% 2.70% 2.90% Relative deviation 3 1.51% 2.82% 2.70% 2.74% 1.75% 2.15%
[0082] Table 2
[0083] As shown in Table 2, the Apo E concentrations measured in Example 1 from 0 to 14 months were close to the true value, and the relative deviations were less than 3%, indicating that the kit of the present invention has good repeatability and accurate measurement. Example 1 is the optimal formulation ratio.
[0084] 2. Prepare a sample with an Apo E concentration of 38.2 mg / L respectively, and repeat the test on the sample using the kit of Example 2. The test results are shown in Table 3:
[0085] / 0 months 4 months 8 months 12 months 13 months 14 months 1 39.4 38.2 38.0 37.2 35.4 35.4 2 38.0 39.5 35.3 39.0 38.2 36.0 3 38.0 36.9 39.7 35.7 36.3 35.8 Theoretical concentration 38.2 38.2 38.2 38.2 38.2 38.2 Relative deviation 1 3.03% -0.10% -0.63% -2.72% -7.43% -7.43% Relative deviation 2 -0.63% 3.29% -7.69% 1.99% -0.10% -5.86% Relative deviation 3 -0.63% -3.50% 3.82% -6.64% -5.07% -6.38%
[0086] Table 3
[0087] As can be seen from Table 3, the Apo E concentrations measured in Example 2 from 0 to 12 months were close to the true value, and the relative deviations were all less than 10%, indicating that the kit of the present invention has good repeatability and accurate measurement.
[0088] 3. Prepare a sample with an Apo E concentration of 46.6 mg / L respectively, and repeat the test on the sample using the kit of Example 3. The test results are shown in Table 4:
[0089] / 0 months 4 months 8 months 12 months 13 months 14 months 1 45.1 46.0 41.9 41.1 40.7 41.1 2 45.7 45.5 40.6 40.9 41.6 40.6 3 47.0 46.0 41.4 40.3 40.8 41.4 Theoretical concentration 46.6 46.6 46.6 46.6 46.6 46.6 Relative deviation 1 -3.11% -1.18% -9.99% -11.71% -12.57% -11.71% Relative deviation 2 -1.83% -2.26% -12.78% -12.14% -10.63% -12.78% Relative deviation 3 0.97% -1.18% -11.06% -13.43% -12.35% -11.06%
[0090] Table 4
[0091] As can be seen from Table 4, the Apo E concentration measured in Example 3 from 8 months to 14 months deviates from the true value, and the relative deviation is less than 10%, indicating that the kit of the present invention has good repeatability and accurate measurement.
[0092] 4. Prepare a sample with an Apo E concentration of 26.8 mg / L respectively, and repeat the test on the sample using the kit of Example 4. The test results are shown in Table 5:
[0093] / 0 months 4 months 8 months 12 months 13 months 14 months 1 27.9 25.5 26.2 24.9 24.7 23.7 2 29.1 26.7 24.1 24.7 24.7 23.9 3 28.7 23.1 26.2 25.7 23.3 28.5 Theoretical concentration 26.8 26.8 26.8 26.8 26.8 26.8 Relative deviation 1 4.10% -4.85% -2.24% -7.09% -7.84% -11.57% Relative deviation 2 8.58% -0.37% -10.07% -7.84% -7.84% -10.82% Relative deviation 3 7.09% -13.81% -2.24% -4.10% -13.06% 6.34%
[0094] Table 5
[0095] As can be seen from Table 5, the Apo E concentration measured in Example 4 at 4 months deviates from the true value, and the relative deviation is greater than 10% after 4 months, indicating that the kit of the present invention has poor repeatability and inaccurate measurement.
[0096] 5. Prepare a sample with an Apo E concentration of 18.4 mg / L respectively, and repeat the test on the sample using the kit of Example 5. The test results are shown in Table 6:
[0097] / 0 months 4 months 8 months 12 months 13 months 14 months 1 17.0 16.4 17.0 16.0 16.6 16.6 2 17.8 17.7 17.1 17.3 16.8 14.5 3 16.2 16.0 18.8 18.1 17.2 15.5 Theoretical concentration 18.4 18.4 17.4 18.4 18.4 18.4 Relative deviation 1 -7.56% -10.82% -2.24% -13.00% -9.73% -9.73% Relative deviation 2 -3.21% -3.75% -1.67% -5.93% -8.65% -21.15% Relative deviation 3 -11.91% -13.00% 8.11% -1.58% -6.47% -15.72%
[0098] Table 6
[0099] As can be seen from Table 6, the Apo E concentrations measured in Example 5 at 0 months deviated from the true value, indicating that the kit of the present invention has poor repeatability and inaccurate measurement.
[0100] In summary, the embodiment 1 with the best performance was selected for bottle opening performance verification:
[0101]
[0102] Table 7
[0103] As can be seen from Table 7, the Apo E concentrations measured in Example 1 from day 0 to day 40 were close to the true value, and the relative deviations were all less than 4%, indicating that the kit of the present invention has good repeatability and accurate measurement.
[0104] Select the embodiment 1 with the best performance to verify the anti-interference performance:
[0105]
[0106] Table 8
[0107] As can be seen from Table 8, Example 1 has less interference with ascorbic acid, hemoglobin, bilirubin and fat emulsion, indicating that the kit of the present invention has good anti-interference performance and accurate measurement.
[0108] The above disclosure is only the preferred embodiment of the anti-interference apolipoprotein E assay kit, preparation method and detection method of the present invention. Of course, this cannot be used to limit the scope of rights of the present invention. Ordinary technicians in this field can understand that all or part of the processes of the above embodiments and equivalent changes made according to the claims of the present invention still fall within the scope of the invention.
Claims
1. A method for preparing an anti-interference apolipoprotein E assay kit, characterized in that: The following steps are involved: Weigh 5-6 parts of polyethylene glycol, 3-12 parts of sodium azide, 2-15 parts of Tween, 1000-1650 parts of purified water, 0.45-0.55 parts of tris(hydroxymethyl)aminomethane) and 15-23 parts of hydrochloric acid respectively, mix well, and filter to obtain a first reagent; Respectively weigh 3-8 parts of water-soluble polyethyleneimine, 1-4 parts of sodium dodecylbenzene sulfonate, 2-5 parts of carboxymethyl chitosan, 2-6 parts of glycerol, 1-4 parts of sodium chloride, 1-3 parts of tris(hydroxymethyl)aminomethane, 0.01-0.02 parts of hydrochloric acid, 1-2 parts of sodium azide, 1-3 parts of citric acid, 3-20 parts of Apo E goat anti-human antibody and 40-55 parts of purified water, mix well, and filter to obtain a second reagent; Add 1 L of standard diluent to Apo E antigen to obtain Apo E calibrator.
2. The method for preparing the interference-resistant apolipoprotein E assay kit according to claim 1, characterized in that: The mixing of the first reagent and the second reagent should be carried out under the condition of 25±3°C.
3. The method for preparing the interference-resistant apolipoprotein E assay kit according to claim 1, characterized in that: The first reagent, the second reagent and the Apo E calibrator are all stored at 2-8°C.
4. The method for preparing the interference-resistant apolipoprotein E assay kit according to claim 1, characterized in that: The Apo E calibrator concentrations include S1 = 0 mg / L, S1 = 12.5 mg / L, S2 = 25.0 mg / L, S3 = 50.0 mg / L and S1 = 100.0 mg / L.
5. An anti-interference apolipoprotein E assay kit, applied to the method for preparing the anti-interference apolipoprotein E assay kit according to any one of claims 1 to 4, characterized in that: Includes a first reagent, a second reagent and an Apo E calibrator.
6. The detection method of the anti-interference apolipoprotein E determination kit, the anti-interference apolipoprotein E determination kit according to claim 5, characterized in that: The following steps are involved: Adding the first reagent to the sample to be tested and mixing to obtain a mixed solution, incubating the first mixed solution at 37° C., and reading a first absorbance at a wavelength of 340 nm; The second reagent is added to the mixed solution and mixed evenly, incubated at 37° C., and the second absorbance is read at a wavelength of 340 nm; Subtracting the second absorbance from the first absorbance to obtain an absorbance difference; The Apo E calibrator is used to fit a standard curve on a fully automatic biochemical analyzer, and the content of Apo E in the sample to be tested is calculated based on the absorbance.
Citation Information
Patent Citations
Method, reagent and kit for quantitatively detecting apolipoprotein E
CN104677844A
Lipid quality control product and preparation method thereof
CN114527288A
Transferrin determination kit with strong anti-interference performance and detection method
CN117647651A
